{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:49:19Z","timestamp":1785268159540,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001075","name":"Channel 7 Children's Research Foundation","doi-asserted-by":"publisher","award":["Channel 7 Children's Research Foundation"],"award-info":[{"award-number":["Channel 7 Children's Research Foundation"]}],"id":[{"id":"10.13039\/501100001075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DEBRA Australia","award":["DEBRA Australia"],"award-info":[{"award-number":["DEBRA Australia"]}]},{"DOI":"10.13039\/100002077","name":"Epidermolysis Bullosa Medical Research Foundation","doi-asserted-by":"publisher","award":["Epidermolysis Bullosa Medical Research Foundation"],"award-info":[{"award-number":["Epidermolysis Bullosa Medical Research Foundation"]}],"id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Epidermolysis bullosa (EB) encompasses a rare, inherited group of skin disorders characterised by skin fragility, leading to painful, chronic wounds. While recent international studies have reported reduced microbial diversity and altered bacterial composition in EB blistered skins, no microbiome or antimicrobial resistance data is available for Australian EB patients. The objectives of this study were to characterise the wound microbiome of Australian EB patients and identify bacterial pathogens and their associated antimicrobial resistance profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 15 chronic wound swabs were collected from 10 EB patients. Bacterial identification was performed using standard culture methods and MALDI-TOF; for a selected resistant subset, whole-genome sequencing (WGS) was conducted on two strains, and full-length 16S rRNA gene sequencing was performed on 10 swab samples. Antimicrobial susceptibility profiles were determined using disk diffusion assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      PacBio Full-length 16S rRNA sequence analysis revealed a high relative abundance of the genera\n                      <jats:italic>Staphylococcus<\/jats:italic>\n                      and\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      , with\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      being the most frequently detected species. Among the 27 cultured bacterial isolates, 81.5% exhibited resistance to at least one antibiotic, and 22.2% were classified as multidrug resistance (MDR). WGS of two selected resistant strains harboured\n                      <jats:italic>blaZ<\/jats:italic>\n                      ,\n                      <jats:italic>mecA<\/jats:italic>\n                      ,\n                      <jats:italic>ermC<\/jats:italic>\n                      and\n                      <jats:italic>mupA<\/jats:italic>\n                      genes conferring resistance to penicillins, cefoxitin, clindamycin and high-level mupirocin, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to profile the wound microbiome and antimicrobial resistance in Australian EB patients. The findings provide the descriptive microbial profiles and resistance patterns, with implications for clinical management of patients in a specific healthcare setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04295-5","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:54:55Z","timestamp":1772898895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Anteneh","family":"Amsalu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanif","family":"Haidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Mirco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Rudolph-Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Antipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8072-4222","authenticated-orcid":false,"given":"Zlatko","family":"Kopecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"1","key":"4295_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan A, Bruckner-Tuderman L, Chapple IL, Fine J-D, Harper N, Has C, et al. Epidermolysis bullosa. Nat reviews Disease primers. 2020;6(1):78.","journal-title":"Nat reviews Disease primers"},{"key":"4295_CR2","doi-asserted-by":"crossref","unstructured":"Hou P-C, Del Agua N, Lwin SM, Hsu C-K, McGrath JA. Innovations in the treatment of dystrophic epidermolysis bullosa (DEB): current landscape and prospects. Ther Clin Risk Manag. 2023:455\u201373.","DOI":"10.2147\/TCRM.S386923"},{"issue":"1","key":"4295_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13023-022-02433-3","volume":"17","author":"JY So","year":"2022","unstructured":"So JY, Fulchand S, Wong CY, Li S, Nazaroff J, Gorell ES, et al. A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex. Orphanet J Rare Dis. 2022;17(1):270.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"4295_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","volume":"152","author":"JD Fine","year":"2016","unstructured":"Fine JD. Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016;152(11):1231\u20138.","journal-title":"JAMA Dermatol"},{"key":"4295_CR5","doi-asserted-by":"crossref","unstructured":"Kim M, Minmin L, Intong-Wheeler LR, Tran K, Marucci D, Murrell DF. Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand. Acta dermato-venereologica. 2018;98(1).","DOI":"10.2340\/00015555-2781"},{"issue":"4","key":"4295_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614\u201327.","journal-title":"Br J Dermatol"},{"key":"4295_CR7","doi-asserted-by":"crossref","unstructured":"McGrath JA, Tolar J. New gene therapies for dystrophic epidermolysis bullosa: progress, promise, and persistent gaps. Oxford University Press; 2025. p. ljaf321.","DOI":"10.1093\/bjd\/ljaf321"},{"issue":"2","key":"4295_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","volume":"60","author":"J-D Fine","year":"2009","unstructured":"Fine J-D, Johnson LB, Weiner M, Li K-P, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006. J Am Acad Dermatol. 2009;60(2):203\u201311.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4295_CR9","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/ncomms6932","volume":"6","author":"E Hoste","year":"2015","unstructured":"Hoste E, Arwert EN, Lal R, South AP, Salas-Alanis JC, Murrell DF, et al. Innate sensing of microbial products promotes wound-induced skin cancer. Nat Commun. 2015;6(1):5932.","journal-title":"Nat Commun"},{"issue":"1","key":"4295_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/pde.13331","volume":"35","author":"HM Singer","year":"2018","unstructured":"Singer HM, Levin LE, Garzon MC, Lauren CT, Planet PJ, Kittler NW, et al. Wound culture isolated antibiograms and caregiver-reported skin care practices in children with epidermolysis bullosa. Pediatr Dermatol. 2018;35(1):92\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"4295_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jid.2016.08.009","volume":"137","author":"M Loesche","year":"2017","unstructured":"Loesche M, Gardner SE, Kalan L, Horwinski J, Zheng Q, Hodkinson BP, et al. Temporal stability in chronic wound microbiota is associated with poor healing. J Invest Dermatology. 2017;137(1):237\u201344.","journal-title":"J Invest Dermatology"},{"issue":"6","key":"4295_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1600-0625.2012.01502.x","volume":"21","author":"MM van der Kooi-Pol","year":"2012","unstructured":"van der Kooi-Pol MM, Veenstra\u2010Kyuchukova YK, Duipmans JC, Pluister GN, Schouls LM, de Neeling AJ, et al. High genetic diversity of S taphylococcus aureus strains colonizing patients with epidermolysis bullosa. Exp Dermatol. 2012;21(6):463\u20136.","journal-title":"Exp Dermatol"},{"issue":"6","key":"4295_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/INF.0000000000003871","volume":"42","author":"L Garc\u00eda-Espinosa","year":"2023","unstructured":"Garc\u00eda-Espinosa L, Del Rosal T, Quintana L, Maseda R, Grasa C, Falces-Romero I, et al. Bloodstream infection in children with epidermolysis bullosa. Pediatr Infect Dis J. 2023;42(6):510\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"4295_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/iwj.13922","volume":"20","author":"I Fuentes","year":"2023","unstructured":"Fuentes I, Yubero MJ, Morand\u00e9 P, Varela C, Or\u00f3stica K, Acevedo F, et al. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. Int Wound J. 2023;20(3):774\u201383.","journal-title":"Int Wound J"},{"issue":"1","key":"4295_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/pde.14444","volume":"38","author":"LE Levin","year":"2021","unstructured":"Levin LE, Shayegan LH, Lucky AW, Hook KP, Bruckner AL, Feinstein JA, et al. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database. Pediatr Dermatol. 2021;38(1):119\u201324.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"4295_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/pde.15383","volume":"40","author":"ME Scollan","year":"2023","unstructured":"Scollan ME, Levin LE, Lucky AW, Hook KP, Peoples K, Bruckner AL, et al. Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa. Pediatr Dermatol. 2023;40(5):863\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"4295_CR17","doi-asserted-by":"publisher","first-page":"2370424","DOI":"10.1080\/09546634.2024.2370424","volume":"35","author":"NS Jayawardena","year":"2024","unstructured":"Jayawardena NS, Wargon O, Tatian AH. the spectrum of antimicrobial resistance in bacteria isolated from wounds of patients with epidermolysis bullosa. J Dermatological Treat. 2024;35(1):2370424.","journal-title":"J Dermatological Treat"},{"issue":"2","key":"4295_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijmm.2013.11.012","volume":"304","author":"MM van der Kooi-Pol","year":"2014","unstructured":"van der Kooi-Pol MM, Duipmans JC, Jonkman MF, van Dijl JM. Host\u2013pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus. Int J Med Microbiol. 2014;304(2):195\u2013203.","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"4295_CR19","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/ijd.15634","volume":"60","author":"JT Santin","year":"2021","unstructured":"Santin JT, Mariath LM, Rossato AM, Schuler-Faccini L, Kiszewski AE. Prevalence and antimicrobial resistance profile of staphylococcus aureus in inherited epidermolysis bullosa: a cross\u2010sectional multicenter study in Brazil. Int J Dermatol. 2021;60(9):1126\u201330.","journal-title":"Int J Dermatol"},{"key":"4295_CR20","unstructured":"Igoucheva O. Longitudinal analysis of disease site activities impairing wound healing in epidermolysis bullosa and development of therapeutic strategies. 2020."},{"issue":"20","key":"4295_CR21","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.3390\/jcm12206435","volume":"12","author":"A Horev","year":"2023","unstructured":"Horev A, Brandwein M, Vaknin A, Motro Y, Moran-Gilad J. Temporal Changes in the Skin Microbiome of Epidermolysis Bullosa Patients following the Application of Wound Dressings. J Clin Med. 2023;12(20):6435.","journal-title":"J Clin Med"},{"issue":"11","key":"4295_CR22","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.jid.2018.04.026","volume":"138","author":"I Fuentes","year":"2018","unstructured":"Fuentes I, Guttmann-Gruber C, Tay ASL, Hofbauer JP, Denil SL, Reichelt J, et al. Reduced microbial diversity is a feature of recessive dystrophic epidermolysis bullosa-involved skin and wounds. J Invest Dermatol. 2018;138(11):2492\u20135.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"4295_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000516354","volume":"13","author":"M Kondo","year":"2021","unstructured":"Kondo M, Takashima S, Goto H, Habe K, Natsuga K, Yamanaka K. Dominance of methicillin-resistant Staphylococcus aureus in a Japanese infant with recessive dystrophic epidermolysis bullosa. Case Rep Dermatol. 2021;13(2):278\u201381.","journal-title":"Case Rep Dermatol"},{"issue":"6","key":"4295_CR24","doi-asserted-by":"publisher","first-page":"e70129","DOI":"10.1111\/exd.70129","volume":"34","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Wang S, Nurxat N, Min X, Guo Y, Chen F, et al. Staphylococcus aureus Promotes Cutaneous Lesions in Patients With Epidermolysis Bullosa. Exp Dermatol. 2025;34(6):e70129.","journal-title":"Exp Dermatol"},{"key":"4295_CR25","unstructured":"Snelson K. Managing wounds in patients with epidermolysis bullosa. Wounds UK. 2020;16(4)."},{"key":"4295_CR26","unstructured":"Swanson T, Angel D, Sussman G, Cooper R, Haesler E, Ousey K, et al. Wound infection in clinical practice: principles of best practice. 2016."},{"key":"4295_CR27","unstructured":"Song E, Robinson S. How to Collect a Wound Swab (Levine Technique) for Culture. WoundReference. 2021. Available from: https:\/\/woundreference.com\/app\/topic."},{"issue":"6","key":"4295_CR28","doi-asserted-by":"publisher","first-page":"e00731","DOI":"10.1128\/spectrum.00731-23","volume":"11","author":"SA Sapula","year":"2023","unstructured":"Sapula SA, Amsalu A, Whittall JJ, Hart BJ, Siderius NL, Nguyen L, et al. The scope of antimicrobial resistance in residential aged care facilities determined through analysis of Escherichia coli and the total wastewater resistome. Microbiol Spectr. 2023;11(6):e00731\u201323.","journal-title":"Microbiol Spectr"},{"issue":"4ts","key":"4295_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"A Bauer","year":"1966","unstructured":"Bauer A, Kirby W, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4ts):493\u20136.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"4295_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/jac\/dki139","volume":"55","author":"XY Han","year":"2005","unstructured":"Han XY, Andrade RA. Brevundimonas diminuta infections and its resistance to fluoroquinolones. J Antimicrob Chemother. 2005;55(6):853\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4295_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"4295_CR32","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1093\/bioinformatics\/btz220","volume":"35","author":"NM Quijada","year":"2019","unstructured":"Quijada NM, Rodr\u00edguez-L\u00e1zaro D, Eiros JM, Hernandez M. TORMES: an automated pipeline for whole bacterial genome analysis. Bioinformatics. 2019;35(21):4207\u201312.","journal-title":"Bioinformatics"},{"issue":"1","key":"4295_CR33","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-019-13036-1","volume":"10","author":"JS Johnson","year":"2019","unstructured":"Johnson JS, Spakowicz DJ, Hong B-Y, Petersen LM, Demkowicz P, Chen L, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10(1):5029.","journal-title":"Nat Commun"},{"issue":"7","key":"4295_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"issue":"4","key":"4295_CR35","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8(4):e61217.","journal-title":"PLoS ONE"},{"issue":"5","key":"4295_CR36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.chom.2019.03.006","volume":"25","author":"LR Kalan","year":"2019","unstructured":"Kalan LR, Meisel JS, Loesche MA, Horwinski J, Soaita I, Chen X, et al. Strain-and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe. 2019;25(5):641\u201355. e5.","journal-title":"Cell Host Microbe"},{"key":"4295_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15776","volume-title":"Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells","author":"A Dermietzel","year":"2025","unstructured":"Dermietzel A, Tosun B, Nguyen M, Wessel K, Rauer L, Neumann AU, et al. Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells. JDDG: Journal der Deutschen Dermatologischen Gesellschaft; 2025."},{"issue":"1","key":"4295_CR38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41467-025-55934-7","volume":"16","author":"N Hirt","year":"2025","unstructured":"Hirt N, Manchon E, Chen Q, Delaroque C, Corneau A, Hemon P, et al. Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa. Nat Commun. 2025;16(1):664.","journal-title":"Nat Commun"},{"issue":"813","key":"4295_CR39","doi-asserted-by":"publisher","first-page":"eadq7985","DOI":"10.1126\/scitranslmed.adq7985","volume":"17","author":"A Jamet","year":"2025","unstructured":"Jamet A, Fu X, Dietrich C, Bellon N, Attailia M, Uyar E, et al. Immune response and clinical severity are shaped by skin-adapted Staphylococcus aureus in chronically infected patients. Sci Transl Med. 2025;17(813):eadq7985.","journal-title":"Sci Transl Med"},{"key":"4295_CR40","unstructured":"Australian Commission on Safety and Quality in Health Care, Sydney, NSW, Australia. AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health \u2013 report. ACSQHC. 2023. https:\/\/www.safetyandquality.gov.au\/publications-and-resources\/resource-library\/aura-2023-fifth-australian-report-antimicrobial-use-and-resistance-human-health-report."},{"issue":"1","key":"4295_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/JCM.00759-10","volume":"49","author":"A Cadilla","year":"2011","unstructured":"Cadilla A, David MZ, Daum RS, Boyle-Vavra S. Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States. J Clin Microbiol. 2011;49(1):95\u2013100.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4295_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhin.2013.09.006","volume":"85","author":"DJ Hetem","year":"2013","unstructured":"Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect. 2013;85(4):249\u201356.","journal-title":"J Hosp Infect"},{"key":"4295_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijso.2020.12.010","volume":"28","author":"MM Alam","year":"2021","unstructured":"Alam MM, Islam MN, Hawlader MDH, Ahmed S, Wahab A, Islam M, et al. Prevalence of multidrug resistance bacterial isolates from infected wound patients in Dhaka, Bangladesh: a cross-sectional study. Int J Surg Open. 2021;28:56\u201362.","journal-title":"Int J Surg Open"},{"issue":"9","key":"4295_CR44","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1128\/JCM.00302-12","volume":"50","author":"E Bathoorn","year":"2012","unstructured":"Bathoorn E, Hetem DJ, Alphenaar J, Kusters JG, Bonten MJ. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J Clin Microbiol. 2012;50(9):2947\u201350.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4295_CR45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12879-025-10943-1","volume":"25","author":"S Manandhar","year":"2025","unstructured":"Manandhar S, Karn D, Shrestha MR, Shakya J, Singh A. Biofilm formation, methicillin resistance and SCC mec types among Staphylococcus aureus isolated from clinical samples from a tertiary care hospital, in Nepal. BMC Infect Dis. 2025;25(1):534.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4295_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/JCM.05124-11","volume":"51","author":"B Cui","year":"2013","unstructured":"Cui B, Smooker PM, Rouch DA, Daley AJ, Deighton MA. Differences between two clinical Staphylococcus capitis subspecies as revealed by biofilm, antibiotic resistance, and pulsed-field gel electrophoresis profiling. J Clin Microbiol. 2013;51(1):9\u201314.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4295_CR47","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/microorganisms13040852","volume":"13","author":"KE Beenken","year":"2025","unstructured":"Beenken KE, Smeltzer MS. Staphylococcus aureus Biofilm-Associated Infections: Have We Found a Clinically Relevant. Target? Microorganisms. 2025;13(4):852.","journal-title":"Target? Microorganisms"},{"issue":"1","key":"4295_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2180-12-104","volume":"12","author":"AJ McCarthy","year":"2012","unstructured":"McCarthy AJ, Lindsay JA. The distribution of plasmids that carry virulence and resistance genes in Staphylococcus aureus is lineage associated. BMC Microbiol. 2012;12(1):104.","journal-title":"BMC Microbiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04295-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04295-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04295-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:34:52Z","timestamp":1781638492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04295-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04295-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the University of South Australia Human Research Ethics Committee (#205664) and Bulberry Ltd. Human Research Ethics Committee (#2022-11-1244-PRE-1). Written informed consent was obtained from all patients prior to their enrolment in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study patients provided written informed consent for their data to be used and published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declared no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}